OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Dynamic light scattering proves a good analytical technique for testing protein stability.
Accelerated drug development timelines must accommodate nonclinical safety studies.
May 02, 2021
Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.
April 29, 2021
A shortage of pipette tips has been attributed to several factors, including the COVID-19 pandemic.
April 01, 2021
Dynamic light scattering presents a good analytical technique for testing protein stability.
March 02, 2021
The need for real-time monitoring and control has spurred the development of new analytical tools.
March 01, 2021
Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.
The companies intend to design and implement algorithms for the early stages of research for drug discovery and development of drug candidates to treat Alzheimer’s disease.
The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.
January 28, 2021
Nexelis’ recent acquisition of GSK’s Marburg, Germany-based vaccines clinical bioanalytical laboratory expands its bioanalytical capabilities.
The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.
January 06, 2021
Demand for specific advanced laboratory skills creates a positive employment market.